107 related articles for article (PubMed ID: 10677373)
1. Mutations in the reduced-folate carrier affect protein localization and stability.
Sadlish H; Murray RC; Williams FM; Flintoff WF
Biochem J; 2000 Mar; 346 Pt 2(Pt 2):509-18. PubMed ID: 10677373
[TBL] [Abstract][Full Text] [Related]
2. Cytoplasmic domains of the reduced folate carrier are essential for trafficking, but not function.
Sadlish H; Williams FM; Flintoff WF
Biochem J; 2002 Jun; 364(Pt 3):777-86. PubMed ID: 12049642
[TBL] [Abstract][Full Text] [Related]
3. Characterization of beta-galactosidase mutations Asp332-->Asn and Arg148-->Ser, and a polymorphism, Ser532-->Gly, in a case of GM1 gangliosidosis.
Zhang S; Bagshaw R; Hilson W; Oho Y; Hinek A; Clarke JT; Callahan JW
Biochem J; 2000 Jun; 348 Pt 3(Pt 3):621-32. PubMed ID: 10839995
[TBL] [Abstract][Full Text] [Related]
4. Sequence alterations in the reduced folate carrier are observed in osteosarcoma tumor samples.
Yang R; Sowers R; Mazza B; Healey JH; Huvos A; Grier H; Bernstein M; Beardsley GP; Krailo MD; Devidas M; Bertino JR; Meyers PA; Gorlick R
Clin Cancer Res; 2003 Feb; 9(2):837-44. PubMed ID: 12576457
[TBL] [Abstract][Full Text] [Related]
5. Atrophic macular degeneration mutations in ELOVL4 result in the intracellular misrouting of the protein.
Ambasudhan R; Wang X; Jablonski MM; Thompson DA; Lagali PS; Wong PW; Sieving PA; Ayyagari R
Genomics; 2004 Apr; 83(4):615-25. PubMed ID: 15028284
[TBL] [Abstract][Full Text] [Related]
6. The reduced folate carrier gene is a novel selectable marker for recombinant protein overexpression.
Rothem L; Berman B; Stark M; Jansen G; Assaraf YG
Mol Pharmacol; 2005 Sep; 68(3):616-24. PubMed ID: 15939798
[TBL] [Abstract][Full Text] [Related]
7. A mutation in the insulin 2 gene induces diabetes with severe pancreatic beta-cell dysfunction in the Mody mouse.
Wang J; Takeuchi T; Tanaka S; Kubo SK; Kayo T; Lu D; Takata K; Koizumi A; Izumi T
J Clin Invest; 1999 Jan; 103(1):27-37. PubMed ID: 9884331
[TBL] [Abstract][Full Text] [Related]
8. Characterization of human torsinA and its dystonia-associated mutant form.
Liu Z; Zolkiewska A; Zolkiewski M
Biochem J; 2003 Aug; 374(Pt 1):117-22. PubMed ID: 12780349
[TBL] [Abstract][Full Text] [Related]
9. Contrasting effects of oncogene expression on two carrier-mediated systems internalizing folate compounds in Fisher rat 3T3 cells.
Kühnel JM; Chiao JH; Sirotnak FM
J Cell Physiol; 2000 Sep; 184(3):364-72. PubMed ID: 10911368
[TBL] [Abstract][Full Text] [Related]
10. Novel CCM1, CCM2, and CCM3 mutations in patients with cerebral cavernous malformations: in-frame deletion in CCM2 prevents formation of a CCM1/CCM2/CCM3 protein complex.
Stahl S; Gaetzner S; Voss K; Brackertz B; Schleider E; Sürücü O; Kunze E; Netzer C; Korenke C; Finckh U; Habek M; Poljakovic Z; Elbracht M; Rudnik-Schöneborn S; Bertalanffy H; Sure U; Felbor U
Hum Mutat; 2008 May; 29(5):709-17. PubMed ID: 18300272
[TBL] [Abstract][Full Text] [Related]
11. A single point mutation resulting in an adversely reduced expression of DPM2 in the Lec15.1 cells.
Pu L; Scocca JR; Walker BK; Krag SS
Biochem Biophys Res Commun; 2003 Dec; 312(3):555-61. PubMed ID: 14680801
[TBL] [Abstract][Full Text] [Related]
12. Alpha 1-antitrypsin nonsense mutation associated with a retained truncated protein and reduced mRNA.
Lee J; Novoradovskaya N; Rundquist B; Redwine J; Saltini C; Brantly M
Mol Genet Metab; 1998 Apr; 63(4):270-80. PubMed ID: 9635295
[TBL] [Abstract][Full Text] [Related]
13. A missense mutation in the OCTN2 gene associated with residual carnitine transport activity.
Wang Y; Kelly MA; Cowan TM; Longo N
Hum Mutat; 2000; 15(3):238-45. PubMed ID: 10679939
[TBL] [Abstract][Full Text] [Related]
14. Reduced folate carrier polymorphism (80A-->G) and neural tube defects.
De Marco P; Calevo MG; Moroni A; Merello E; Raso A; Finnell RH; Zhu H; Andreussi L; Cama A; Capra V
Eur J Hum Genet; 2003 Mar; 11(3):245-52. PubMed ID: 12673279
[TBL] [Abstract][Full Text] [Related]
15. Genetic and epigenetic alterations of the reduced folate carrier in untreated diffuse large B-cell lymphoma.
Kastrup IB; Worm J; Ralfkiaer E; Hokland P; Guldberg P; Grønbaek K
Eur J Haematol; 2008 Jan; 80(1):61-6. PubMed ID: 18028428
[TBL] [Abstract][Full Text] [Related]
16. Loss of membrane targeting of Vangl proteins causes neural tube defects.
Iliescu A; Gravel M; Horth C; Kibar Z; Gros P
Biochemistry; 2011 Feb; 50(5):795-804. PubMed ID: 21142127
[TBL] [Abstract][Full Text] [Related]
17. Mutational analysis of the karmellae-inducing signal in Hmg1p, a yeast HMG-CoA reductase isozyme.
Profant DA; Roberts CJ; Wright RL
Yeast; 2000 Jun; 16(9):811-27. PubMed ID: 10861905
[TBL] [Abstract][Full Text] [Related]
18. [Analysis, identification and correction of some errors of model refseqs appeared in NCBI Human Gene Database by in silico cloning and experimental verification of novel human genes].
Zhang DL; Ji L; Li YD
Yi Chuan Xue Bao; 2004 May; 31(5):431-43. PubMed ID: 15478601
[TBL] [Abstract][Full Text] [Related]
19. Cloning and characterization of a novel endoplasmic reticulum localized G-patch domain protein, IER3IP1.
Yiu WH; Poon JW; Tsui SK; Fung KP; Waye MM
Gene; 2004 Aug; 337():37-44. PubMed ID: 15276200
[TBL] [Abstract][Full Text] [Related]
20. A temperature-sensitive splicing mutation in the bimG gene of Aspergillus produces an N-terminal fragment which interferes with type 1 protein phosphatase function.
Hughes M; Arundhati A; Lunness P; Shaw PJ; Doonan JH
EMBO J; 1996 Sep; 15(17):4574-83. PubMed ID: 8887549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
